Pancreatic Cancer Research

ResearcherNational and Kapodistrian University of AthensActive in the last 2 years

Michalis V. Karamouzis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1369-8201; OpenAlex author ID A5084550691. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 3 papers · 2021: 4 papers · 2022: 3 papers · 2023: none · 2024: 2 papers

Papers 13

  1. l-Securinine Induces ROS-Dependent Apoptosis on Pancreatic Cancer Cells via the PI3K/AKT/mTOR Signaling Pathway. Co-author DOI 10.1002/jbt.70036↗
  2. Retraction: Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Last author DOI 10.18632/oncotarget.28601↗
  3. The impact of thromboprophylaxis with LMWHs on the survival of patients with pancreatic cancer. First author DOI 10.1016/j.thromres.2022.02.004↗
  4. The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. Last author DOI 10.3390/genes13101868↗
  5. Pancreatic Cancer Prognosis, Malnutrition Risk, and Quality of Life: A Cross-Sectional Study. Last author DOI 10.3390/nu14030442↗
  6. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC). First author DOI 10.1097/coc.0000000000000826↗
  7. Combinatorial Treatment of Tinzaparin and Chemotherapy can Induce a Significant Antitumor Effectin Pancreatic Cancer Last author DOI 10.21203/rs.3.rs-551892/v1↗
  8. The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study. Co-author DOI 10.3390/cancers13122884↗
  9. Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer. Last author DOI 10.3390/ijms22137053↗
  10. Immunotherapy for pancreatic cancer: A 2020 update. Last author DOI 10.1016/j.ctrv.2020.102016↗
  11. Pancreatic Cancer and Cachexia-Metabolic Mechanisms and Novel Insights. Last author DOI 10.3390/nu12061543↗
  12. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. Last author DOI 10.4251/wjgo.v12.i2.173↗
  13. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Last author DOI 10.18632/oncotarget.23164↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Panagiotis Sarantis · 9 shared papers, 2020–2024 · strength 1.54
  2. Evangelos Koustas · 7 shared papers, 2020–2024 · strength 0.99
  3. Athanasios G. Papavassiliou · 6 shared papers, 2018–2024 · strength 0.95
  4. Pavlos Papakotoulas · 5 shared papers, 2018–2024 · strength 0.78
  5. Dimitriοs Schizas · 5 shared papers, 2020–2021 · strength 0.59
  6. Evangelos S. Felekouras · 4 shared papers, 2021 · strength 0.48
  7. Alexandros Papalampros · 4 shared papers, 2021 · strength 0.48
  8. Chrysovalantou Mihailidou · 2 shared papers, 2018–2024 · strength 0.43
  9. Kalliopi‐Anna Poulia · 2 shared papers, 2020–2022 · strength 0.35
  10. Stamatios E Theocharis · 2 shared papers, 2021 · strength 0.25
  11. Ioanna A. Anastasiou · 1 shared paper, 2024 · strength 0.21
  12. Nikolaοs Tentolouris · 1 shared paper, 2024 · strength 0.21
  13. Nikolaos Garmpis · 1 shared paper, 2022 · strength 0.15
  14. Eleni-Myrto Trifylli · 1 shared paper, 2022 · strength 0.15
  15. Christos Damaskos · 1 shared paper, 2022 · strength 0.15
  16. Athanasios S. Petrou · 1 shared paper, 2021 · strength 0.12
  17. Dimitrios Oikonomou · 1 shared paper, 2021 · strength 0.12
  18. Nikolaos Dimitrokallis · 1 shared paper, 2021 · strength 0.12
  19. Demetris Papamichael · 1 shared paper, 2021 · strength 0.12
  20. Dimitrios Moris · 1 shared paper, 2021 · strength 0.12
  21. Dimitrios C. Ziogas · 1 shared paper, 2020 · strength 0.11
  22. Christo Kole · 1 shared paper, 2020 · strength 0.11
  23. Georgios Fotios Samelis · 1 shared paper, 2021 · strength 0.11
  24. Efstathios Antoniou · 1 shared paper, 2021 · strength 0.11
  25. Georgios Charalambos Sotiropoulos · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.